全文获取类型
收费全文 | 1897篇 |
免费 | 148篇 |
国内免费 | 17篇 |
学科分类
医药卫生 | 2062篇 |
出版年
2021年 | 31篇 |
2020年 | 17篇 |
2019年 | 27篇 |
2018年 | 33篇 |
2017年 | 45篇 |
2016年 | 32篇 |
2015年 | 63篇 |
2014年 | 65篇 |
2013年 | 77篇 |
2012年 | 119篇 |
2011年 | 131篇 |
2010年 | 84篇 |
2009年 | 66篇 |
2008年 | 120篇 |
2007年 | 113篇 |
2006年 | 107篇 |
2005年 | 108篇 |
2004年 | 79篇 |
2003年 | 97篇 |
2002年 | 83篇 |
2001年 | 70篇 |
2000年 | 66篇 |
1999年 | 60篇 |
1998年 | 27篇 |
1997年 | 15篇 |
1996年 | 13篇 |
1995年 | 14篇 |
1994年 | 11篇 |
1993年 | 11篇 |
1992年 | 29篇 |
1991年 | 15篇 |
1990年 | 12篇 |
1989年 | 19篇 |
1988年 | 12篇 |
1987年 | 16篇 |
1986年 | 18篇 |
1985年 | 19篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1976年 | 13篇 |
1975年 | 9篇 |
1974年 | 15篇 |
1973年 | 8篇 |
1971年 | 7篇 |
1970年 | 5篇 |
1969年 | 5篇 |
排序方式: 共有2062条查询结果,搜索用时 15 毫秒
81.
Ming-Hung Hu Yuan-Bin Yu Yu-Chung Huang Jyh-Pyng Gau Liang-Tsai Hsiao Jin-Hwang Liu Ming-Huang Chen Tzeon-Jye Chiou Po-Min Chen Cheng-Hwai Tzeng Chun-Yu Liu 《Annals of hematology》2014,93(6):1023-1029
Patients with immune thrombocytopenia (ITP) may be at increased risk of infection because of the steroids and other immunosuppressive agents used in its treatment. This study aimed to identify events that are associated with infection within 6 months of diagnosis and the impact that infection has on survival. We retrospectively evaluated 239 patients (107 men, 132 women; median age 61 years) diagnosed between January 1997 and August 2011. Every patient received steroid treatment according to the platelet count and the extent of bleeding. Logistic regression analysis was used to identify risk factors associated with the development of infection within 6 months of ITP being diagnosed. Sixty-two patients (25.9 %) developed an infection within 6 months of diagnosis. Multivariate analysis revealed that a lower absolute lymphocyte count (ALC) at diagnosis (<1?×?109/l) was an independent risk factor for infection (P?=?0.039; 95 % confidence interval, 1.033–3.599; odds ratio, 1.928). The time to infection event is significant shorter in those of low ALC, compared with those of higher ALC (P?=?0.032). Furthermore, the 1-year mortality rate after ITP diagnosis was significantly higher in those patients who developed an infection (P?=?0.001). ITP patients with a low absolute lymphocyte count at diagnosis have an increased risk of infection, and those who develop infections have lower 1-year survival. 相似文献
82.
Hao-Yuan Wang Ching-Fen Yang Tzeon-Jye Chiou Sheng-Hsiang Yang Jyh-Pyng Gau Yuan-Bin Yu Chun-Yu Liu Jin-Hwang Liu Po-Min Chen Hui-Chi Hsu Chang-Phone Fung Cheng-Hwai Tzeng Liang-Tsai Hsiao 《Medicine》2014,93(27)
Delayed diagnosis of hematological malignancies in immunocompetent patients with fever of unknown origin (FUO) remains an exhausting challenge for non-hematologist physicians. This retrospective cohort study aimed to establish a scoring system, “bone marrow (BM) score”, to identify FUO patients who require early bone marrow biopsy (BMB) to diagnose hematological disease.Two cohorts, comprising 85 (training) and 20 (validation) eligible immunocompetent patients, with FUOs diagnosed between January 1, 2006 and July 31, 2013, underwent BMBs and were enrolled in the study. Demographic, laboratory, imaging, diagnostic, and outcome data were collected and retrospectively analyzed. Factors associated with hematological etiologies diagnosed using BMBs in the training cohort were identified and scored according to the relative hazards. These were further validated using the validation cohort.For the training cohort, 29 of 85 (34.1%) patients had hematological etiologies diagnosed using BMB. Seven factors significantly predicted the diagnostic yield of hematological diseases in the BM and were scored, with the 6 points for leucoerythroblastic changes in peripheral blood smears, 5.5 for elevated ferritin level (>1000 ng/mL), 4 for splenomegaly, 2 for thrombocytopenia, 1.5 for each of elevated lactate dehydrogenase levels and anemia, and 1 for neutropenia. When the cut-off value of the scoring system was set to 6, its sensitivity and specificity to diagnose hematological diseases in the BM of immunocompetent FUO patients were 93% and 58%, respectively. For the validation cohort, 7 of 20 (35%) patients had hematological disease, and all had BM scores higher than the cut-off, with the sensitivity and specificity at 100% and 77%, respectively.As immunocompetent FUO patients with hematological disease have poor prognoses, the “BM score” is valuable for non-hematologist physicians to identify immunocompetent FUO patients requiring early BMB. 相似文献
83.
84.
A. V. Bennett D. L. Patrick D. M. Bushnell C. F. Chiou P. Diehr 《Quality of life research》2011,20(5):769-777
Purpose
Patient reporting of type 2 diabetes symptoms in a questionnaire with a 7-day recall period was expected to be different from symptom reports using a 7-day diary with repeated 24-h recall based on cognitive theory of memory processes and prior literature. This study compared these two types of recall in patients diagnosed with type 2 diabetes (T2D). 相似文献85.
Feng-Rong Chuang Te-Chuan Chen I-Kuan Wang Chung-Hua Chuang Hsueh-Wen Chang Terry Ting-Yu Chiou 《Renal failure》2013,35(3):181-188
Background. Nephropathy associated with contrast medium exposure is a well-known complication of IVP. However, it is uncertain whether iso-osmolar non-iodinated contrast medium (iodixanol) is less nephrotoxic than low-osmolar contrast medium (iohexol). Materials and Methods. In this single-center, double-blind, prospective study, 50 patients undergoing IVP were randomized into two groups receiving different contrast medium: iodixanol and iohexol. Patients in high risk for contrast nephropathy were included, 28 with renal insufficiency and 19 with diabetes mellitus. We compared the nephrotoxic effect (contrast nephropathy), complement and cytokines profile between the iodixanol and iohexol groups. The mean volume of contrast medium in each IVP procedure was 0.8 mL/kg. Results. The incidence of contrast nephropathy was 4 percent among all patients (one iodixanol and one iohexol). We found no significant differences in contrast nephropathy and allergic reactions between the two groups. There was no significant difference in cytokine profiles in both groups (p > 0.05).The incidence of allergic reaction was 16 percent among all patients. Twelve percent (3/25) had late reaction after iohexol exposure compared to four percent (2/25) with iodixanol (p = 1.0). One patient had severe skin rash due to late adverse reaction after iodixanol. No mortality was found. Conclusions. New iodixanol and iohexol contrast medium for routine IVP examination are safe and have low nephrotoxicity profile, especially in elderly or high-risk patients. Iodixanol contrast medium has an increased risk to induce severe late adverse reaction compared to iohexol. Allergic reaction may be the main adverse effect after contrast medium infusion. 相似文献
86.
87.
88.
89.
90.
P-C Fan P-H Kuo S-H Chang W-T Lee R-M Wu & L-C Chiou 《Cephalalgia : an international journal of headache》2009,29(8):883-890
To investigate the role of plasma calcitonin gene-related peptide (CGRP) in paediatric migraine, we prospectively collected 134 blood samples during or between attacks from 66 migraine, 33 non-migraine headache (non-migraine) and 22 non-headache patients, aged 4–18 years. Plasma CGRP concentrations were measured by enzyme-linked immunosorbent assay and disability by Pediatric MIgraine Disability ASsessment (PedMIDAS) questionnaire. Migraineurs had higher plasma CGRP levels than non-migraine patients ( P = 0.007). The attack level was higher than the non-attack level in migraine ( P = 0.036), but not in non-migraine, patients. This was also revealed in paired comparison ( n = 9, P = 0.015 vs. n = 4, P = 0.47). Using a threshold of 55.1 pg/ml, the sensitivity of the attack level in predicting migraine was 0.81, and specificity 0.75. The PedMIDAS score tended to be higher in the high CGRP (> 200 pg/ml, n = 7) group than in the low (< 200 pg/ml, n = 33) group (26.07 vs. 19.32, P = 0.16) using Mann–Whitney test. Plasma CGRP is useful for diagnosis in paediatric migraine. 相似文献